Solid Biosciences Inc.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 101
- Market Cap
- $353.1M
- Website
- http://www.solidbio.com
Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE)
- Conditions
- Duchenne Muscular Dystrophy
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-09-08
- Last Posted Date
- 2025-09-08
- Lead Sponsor
- Solid Biosciences Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT07160634
A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
- Conditions
- Catecholaminergic Polymorphic Ventricular Tachycardia
- Interventions
- First Posted Date
- 2025-08-29
- Last Posted Date
- 2025-08-29
- Lead Sponsor
- Solid Biosciences Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT07148089
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
- Conditions
- Duchenne Muscular Dystrophy
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2025-09-09
- Lead Sponsor
- Solid Biosciences Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06138639
- Locations
- 🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸University of California, Los Angeles Medical Center, Los Angeles, California, United States
Evaluation of Home Based Assessments on Participants With DMD
- Conditions
- Duchenne Muscular Dystrophy
- First Posted Date
- 2022-12-20
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Solid Biosciences Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT05657938
- Locations
- 🇺🇸
Solid Biosciences, Charlestown, Massachusetts, United States
Microdystrophin Gene Transfer Study in Adolescents and Children With DMD
- Conditions
- Duchenne Muscular Dystrophy
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2025-09-09
- Lead Sponsor
- Solid Biosciences Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03368742
- Locations
- 🇺🇸
David Geffen School of Medicine at UCLA, Los Angeles, California, United States
🇺🇸University of Florida, Gainesville, Florida, United States